Literature DB >> 28880024

Dyslipidaemia: Monoclonal antibody targeting lipoprotein-bound human apoC-III.

Karina Huynh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28880024     DOI： 10.1038/nrcardio.2017.140

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels.

Authors:  Sumeet A Khetarpal; Xuemei Zeng; John S Millar; Cecilia Vitali; Amritha Varshini Hanasoge Somasundara; Paolo Zanoni; James A Landro; Nicole Barucci; William J Zavadoski; Zhiyuan Sun; Hans de Haard; Ildikó V Toth; Gina M Peloso; Pradeep Natarajan; Marina Cuchel; Sissel Lund-Katz; Michael C Phillips; Alan R Tall; Sekar Kathiresan; Paul DaSilva-Jardine; Nathan A Yates; Daniel J Rader
Journal:  Nat Med       Date:  2017-08-21       Impact factor: 53.440
  1 in total
  1 in total

1.  Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7.

Authors:  Renato Quispe; Aditya D Hendrani; Behnoud Baradaran-Noveiry; Seth S Martin; Emily Brown; Krishnaji R Kulkarni; Maciej Banach; Peter P Toth; Eliot A Brinton; Steven R Jones; Parag H Joshi
Journal:  Arch Med Sci       Date:  2019-08-22       Impact factor: 3.318
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.